Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation-Reference-Cited by-同舟云学术

Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation

Published:2016-12-05 Issue:1 Volume:127 Page:349-364
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Cao Juxiang,Tyburczy Magdalena E.,Moss Joel,Darling Thomas N.,Widlund Hans R.,Kwiatkowski David J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference94 articles.

1. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference;Northrup,2013

2. TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1

3. Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-25–5p in exosomes derived from UVB-induced fibroblasts regulates melanogenesis via TSC2-dominated cellular organelle dysfunction;Journal of Dermatological Science;2024-08

2. Rapamycin vs TORin-1 or Gleevec vs Nilotinib: Simple chemical evolution that converts PAK1-blockers to TOR-blockers or vice versa?;Drug Discoveries & Therapeutics;2024-04-30

3. Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation;British Journal of Dermatology;2024-03-15

4. The enhanced hepatotoxicity of isobavachalcone in depigmented zebrafish due to calcium signaling dysregulation and lipid metabolism disorder;Journal of Applied Toxicology;2024-02-24

5. mTORC1 activity negatively regulates human hair follicle growth and pigmentation;EMBO reports;2023-05-22